Human GDF2(Growth Differentiation Factor 2) ELISA Kit

Human GDF2(Growth Differentiation Factor 2) ELISA Kit

To Order Contact us below: [email protected]

Breast Tissue Slide (Well Differentiated Carcinoma)

10-012-10um 10 um
EUR 241.8

Breast Tissue Slide (Well Differentiated Carcinoma)

10-012-4um 4 um
EUR 216.6

Breast Tissue Slide (Poorly Differentiated Carcinoma)

10-013-10um 10 um
EUR 241.8

Breast Tissue Slide (Poorly Differentiated Carcinoma)

10-013-4um 4 um
EUR 216.6

Malaria Differential P.f/P.v Ag test

05FK80 25 tests/kit
EUR 59.4

Malaria Differential P.f/Pan Ag Test (pLDH)

05FK40 25 tests/kit
EUR 59.4

Malaria Differential P.f/Pan Ag Test (HRP II+ pLDH)

05FK60 25 tests/kit
EUR 148.5

Malaria Differential P.f/Pan Ag Test (HRP II+ pLDH) POCT (Lancet, Capillary tube, Alcohol swab Incld.)

05FK63 1 tests/kit
EUR 148.5

Human hypoxia-inducible transcription factor 1 alpha (HIF-1 alpha) ELISA Kit, 96 tests, Quantitative

100-530-HIF 1 Kit
EUR 854.4

Human Growth Hormone antibody

10-2386 500 ug
EUR 222
Description: Mouse Monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-2387 500 ug
EUR 288
Description: Mouse Monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-2388 500 ug
EUR 222
Description: Mouse Monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-G05B 1 mg
EUR 1460
Description: Mouse monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-G05C 1 mg
EUR 131
Description: Mouse monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-G05D 1 mg
EUR 131
Description: Mouse monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-G119A 1 mg
EUR 326
Description: Mouse monoclonal Human Growth Hormone antibody

Human Growth Hormone antibody

10-G119B 1 mg
EUR 326
Description: Mouse monoclonal Human Growth Hormone antibody

Human Tissue factor Recombinant Protein

100-158a 10 µg
EUR 196.35
Description: Tissue factor is a transmembrane glycoprotein of the cytokine receptor superfamily that acts as a receptor for coagulation factor VII (fVII) to trigger initiation of the coagulation cascade in response to vascular injury. Expression of tissue factor occurs constitutively within most extravascular and perivascular cells and at high levels within critical organs and tissue. Tissue factor is not normally expressed freely on the surface of circulating blood cells due to its pro‐coagulant effect, but is instead stored on the surface of mononuclear and endothelial cells in microparticles that can shed into circulation in response to vascular injury, pro‐inflammatory cytokines, or microbial ligands. Tissue factor can also be shed into circulation by cancer cells where its expression in a number of cancer types has been linked to tumor progression, metastatic potential, thrombosis, and angiogenesis. Expression of tissue factor has been shown to be inducible by select cytokines in a number of cell types, includingIL‐1β and TNF‐α in vascular endothelial cells and macrophages, and TNF‐α, IL‐6, and FGF‐Basic in monocytes, among others. The CHO cell-derived Recombinant Human Tissue Factor is a 227-amino-acid length glycoprotein containing a C-terminal His-Tag and has a calculated molecular weight of 25.8 kDa. Due to glycosylation, Recombinant Human Tissue Factor migrates with an apparent molecular mass of approximately 30-40 kDa by SDS-PAGE gel under reducing and non-reducing conditions.

Human Tissue factor Recombinant Protein

100-158aS 2 µg
EUR 92.4
Description: Tissue factor is a transmembrane glycoprotein of the cytokine receptor superfamily that acts as a receptor for coagulation factor VII (fVII) to trigger initiation of the coagulation cascade in response to vascular injury. Expression of tissue factor occurs constitutively within most extravascular and perivascular cells and at high levels within critical organs and tissue. Tissue factor is not normally expressed freely on the surface of circulating blood cells due to its pro‐coagulant effect, but is instead stored on the surface of mononuclear and endothelial cells in microparticles that can shed into circulation in response to vascular injury, pro‐inflammatory cytokines, or microbial ligands. Tissue factor can also be shed into circulation by cancer cells where its expression in a number of cancer types has been linked to tumor progression, metastatic potential, thrombosis, and angiogenesis. Expression of tissue factor has been shown to be inducible by select cytokines in a number of cell types, includingIL‐1β and TNF‐α in vascular endothelial cells and macrophages, and TNF‐α, IL‐6, and FGF‐Basic in monocytes, among others. The CHO cell-derived Recombinant Human Tissue Factor is a 227-amino-acid length glycoprotein containing a C-terminal His-Tag and has a calculated molecular weight of 25.8 kDa. Due to glycosylation, Recombinant Human Tissue Factor migrates with an apparent molecular mass of approximately 30-40 kDa by SDS-PAGE gel under reducing and non-reducing conditions.

Human Growth Hormone Recombinant Protein

100-076 50 µg
EUR 196.35
Description: Growth Hormone (GH), also known as somatotropin, is a pleiotropic cytokine of the hematopoietic growth factor superfamily, which encompasses most cytokines, hematopoietic growth factors, and related receptors, and includes the related growth hormone receptor, prolactin, placental lactogens, proliferins, and somatolactin (SST). GH is primarily recognized for its anabolic role in stimulating the growth and differentiation of muscle, bone, and cartilage. A number of other functions, including immunomodulatory actions, are also attributed to GH, due in part to the pervasive distribution of its receptors, and the indirect effects associated with GH-stimulated production of insulin-like growth factors (IGFs). Occurring predominantly in the somatotropes of the anterior pituitary, whereupon it is stored in secretory granules, production of GH has also been noted in many other tissues, including those of the hematopoietic system. The production and pulsatile release of circulating GH is very tightly regulated by both negative and positive feedback regulations of pituitary and hypothalamic hormones, such as Pituitary-specific Positive Transcription Factor 1 (POU1F1), Growth Hormone Releasing Hormone (GHRH), and somatostatin (SRIF). Deficient production of GH is associated with dwarfism and reduction of lean body mass, while overproduction is associated with acromegaly and gigantism, as well as breast tumor growth. Recombinant Human Growth Hormone is a 22.3 kDa, single, non-glycosylated polypeptide chain containing 192 amino acid residues.

Human Growth Hormone Recombinant Protein

100-076S 10 µg
EUR 92.4
Description: Growth Hormone (GH), also known as somatotropin, is a pleiotropic cytokine of the hematopoietic growth factor superfamily, which encompasses most cytokines, hematopoietic growth factors, and related receptors, and includes the related growth hormone receptor, prolactin, placental lactogens, proliferins, and somatolactin (SST). GH is primarily recognized for its anabolic role in stimulating the growth and differentiation of muscle, bone, and cartilage. A number of other functions, including immunomodulatory actions, are also attributed to GH, due in part to the pervasive distribution of its receptors, and the indirect effects associated with GH-stimulated production of insulin-like growth factors (IGFs). Occurring predominantly in the somatotropes of the anterior pituitary, whereupon it is stored in secretory granules, production of GH has also been noted in many other tissues, including those of the hematopoietic system. The production and pulsatile release of circulating GH is very tightly regulated by both negative and positive feedback regulations of pituitary and hypothalamic hormones, such as Pituitary-specific Positive Transcription Factor 1 (POU1F1), Growth Hormone Releasing Hormone (GHRH), and somatostatin (SRIF). Deficient production of GH is associated with dwarfism and reduction of lean body mass, while overproduction is associated with acromegaly and gigantism, as well as breast tumor growth. Recombinant Human Growth Hormone is a 22.3 kDa, single, non-glycosylated polypeptide chain containing 192 amino acid residues.

Human Interleukin 2 (IL-2) ELISA Kit, 96 tests, quantitative

100-410-IL2 1 kit
EUR 578.4

Human Angiopoietin-2 (Ang-2) ELISA Kit, 96 tests, Quantitative

100-180-APH 1 Kit
EUR 854.4

Human Cyclooxygenase-2 (Cox-2) ELISA Kit, 96 tests, Quantitative

100-200-CX2 1 kit
EUR 1074

Human beta-Defensin-2 (BD-2) ELISA Kit, 96 tests, Quantitative

100-250-BD2 1 Kit
EUR 1074

Human Growth Hormone (Animal Free) Recombinant Protein

100-076-AF 50 µg
EUR 229.95
Description: Growth Hormone (GH), also known as somatotropin, is a pleiotropic cytokine of the hematopoietic growth factor superfamily, which encompasses most cytokines, hematopoietic growth factors, and related receptors, and includes the related growth hormone receptor, prolactin, placental lactogens, proliferins, and somatolactin (SST). GH is primarily recognized for its anabolic role in stimulating the growth and differentiation of muscle, bone, and cartilage. A number of other functions, including immunomodulatory actions, are also attributed to GH, due in part to the pervasive distribution of its receptors, and the indirect effects associated with GH-stimulated production of insulin-like growth factors (IGFs). Occurring predominantly in the somatotropes of the anterior pituitary, whereupon it is stored in secretory granules, production of GH has also been noted in many other tissues, including those of the hematopoietic system. The production and pulsatile release of circulating GH is very tightly regulated by both negative and positive feedback regulations of pituitary and hypothalamic hormones, such as Pituitary-specific Positive Transcription Factor 1 (POU1F1), Growth Hormone Releasing Hormone (GHRH), and somatostatin (SRIF). Deficient production of GH is associated with dwarfism and reduction of lean body mass, while overproduction is associated with acromegaly and gigantism, as well as breast tumor growth. Recombinant Human Growth Hormone is a 22.1 kDa, single, non-glycosylated polypeptide chain containing 191 amino acid residues.

Human Growth Hormone (Animal Free) Recombinant Protein

100-076S-AF 10 µg
EUR 134.4
Description: Growth Hormone (GH), also known as somatotropin, is a pleiotropic cytokine of the hematopoietic growth factor superfamily, which encompasses most cytokines, hematopoietic growth factors, and related receptors, and includes the related growth hormone receptor, prolactin, placental lactogens, proliferins, and somatolactin (SST). GH is primarily recognized for its anabolic role in stimulating the growth and differentiation of muscle, bone, and cartilage. A number of other functions, including immunomodulatory actions, are also attributed to GH, due in part to the pervasive distribution of its receptors, and the indirect effects associated with GH-stimulated production of insulin-like growth factors (IGFs). Occurring predominantly in the somatotropes of the anterior pituitary, whereupon it is stored in secretory granules, production of GH has also been noted in many other tissues, including those of the hematopoietic system. The production and pulsatile release of circulating GH is very tightly regulated by both negative and positive feedback regulations of pituitary and hypothalamic hormones, such as Pituitary-specific Positive Transcription Factor 1 (POU1F1), Growth Hormone Releasing Hormone (GHRH), and somatostatin (SRIF). Deficient production of GH is associated with dwarfism and reduction of lean body mass, while overproduction is associated with acromegaly and gigantism, as well as breast tumor growth. Recombinant Human Growth Hormone is a 22.1 kDa, single, non-glycosylated polypeptide chain containing 191 amino acid residues.

Human Arginine (Arg) ELISA Kit, 96 tests

100-330-ARG 1 kit
EUR 1302

Factor V antibody

10-F77A 100 ug
EUR 197
Description: Mouse monoclonal Factor V antibody

Factor IX antibody

10-F81A 100 ug
EUR 186
Description: Mouse monoclonal Factor IX antibody

Human Citrulline (CIT) ELISA Kit, 96 tests

100-320-CIT 1 kit
EUR 1448.4

Factor VIII antibody

10-F80A 250 ug
EUR 95
Description: Mouse monoclonal Factor VIII antibody

Factor VIIIc antibody

10-F60A 500 ug
EUR 182
Description: Mouse monoclonal Factor VIIIc antibody

Rheumatoid Factor antibody

10-R40A 500 ug
EUR 429
Description: Mouse monoclonal Rheumatoid Factor antibody

Human Angiogenin ELISA Kit, 96 tests, Quantitative

100-160-ANH 1 Kit
EUR 854.4

Human TNF-alpha ELISA Kit, 96 tests, Quantitative

100-215-TNH 1 kit
EUR 578.4

Human Resistin /FIZZ3 ELISA Kit, 96 tests, Quantitative

100-110-RSH 1 Kit
EUR 854.4

MRC-5 Cell Growth Medium

10-210125 125 mL Ask for price

Human Procalcitonin (PCT) ELISA Kit, 96 tests, Quantitative

0380-PTC 1 kit
EUR 927.6

Human Adiponectin (Acrp30) ELISA Kit, 96 tests, Quantitative

100-140-ADH 1 Kit
EUR 708

Human Leptin ELISA Kit, 96 tests, Quantitative, 96 tests

100-135-LEH 1 kit
EUR 781.2

Human Insulin ELISA Kit, 96 tests, Quantitative, 96 tests

0030N 1 kit
EUR 708

Human Symmetrical Dimethylarginine (SDMA) ELISA Kit, 96 tests

100-340-SDM 1 kit
EUR 927.6

Human Cathepsin D (CTHD) ELISA Kit, 96 tests, quantitative

100-620-CDH 1 kit
EUR 1000.8

Human Cathepsin S (CTSS) ELISA Kit, 96 tests, quantitative

100-700-CSH 1 kit
EUR 1000.8

Human Asymmetrical Dimethylarginine (ADMA) ELISA Kit, 96 tests

100-310-ADM 1 kit
EUR 1009.2

Human Calcitonin ELISA Kit, ultrasensitive, 96 tests, Quantitative

0390-CTU 1 kit
EUR 927.6

Human Bone Sialoprotein (BSP) ELISA Kit, 96 tests, Quantitative

100-350-BSP 1 Kit
EUR 1074

Human Parathyroid Hormone (PTH) ELISA Kit, 96 tests, Quantitative

0320-PTH 1 kit
EUR 927.6

Human beta-defensin 5 (BD5) ELISA Kit, 96 tests, Quantitative

100-265-BD5 1 Kit
EUR 1074

Human Cathepsin E (CTSE/CATE) ELISA Kit, 96 tests, quantitative

100-660-CEH 1 kit
EUR 1000.8

Human Angiopoietin-1 (Ang-1) ELISA Kit, 96 tests, Quantitative

100-170-APH 1 Kit
EUR 854.4

Human beta-defensin 105 (BD105) ELISA Kit, 96 tests, Quantitative

100-270-BD105 1 Kit
EUR 1074

Human beta-defensin 119 (BD119) ELISA Kit, 96 tests, Quantitative

100-275-BD119 1 Kit
EUR 1074

Human beta-defensin 124 (BD124) ELISA Kit, 96 tests, Quantitative

100-280-BD124 1 Kit
EUR 1074

Human beta-defensin 126 (BD126) ELISA Kit, 96 tests, Quantitative

100-285-BD126 1 Kit
EUR 1074

Human beta-defensin 127 (BD127) ELISA Kit, 96 tests, Quantitative

100-290-BD127 1 Kit
EUR 1074

Human beta-defensin 129 (BD129) ELISA Kit, 96 tests, Quantitative

100-295-BD129 1 Kit
EUR 1074

Bacillus anthracis antibody (Lethal Factor)

10-7841 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis antibody (Lethal Factor)

Bacillus anthracis antibody (Lethal Factor)

10-7842 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis antibody (Lethal Factor)

Bacillus anthracis antibody (Lethal Factor)

10-B107A 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis antibody (Lethal Factor)

Bacillus anthracis antibody (Lethal Factor)

10-B107B 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis antibody (Lethal Factor)

Human Insulin-Biotin ELISA Kit, 96 tests, Quantitative, 96 tests

0030-20-I 1 kit
EUR 854.4

Human beta-Defensin-1 (BD-1) ELISA Kit, 96 tests, Quantitative

100-240-BD1 1 kit
EUR 1074

Human beta-Defensin-3 (BD-3) ELISA Kit, 96 tests, Quantitative

100-260-BD3 1 kit
EUR 1074

Human Brain Natriuretic Peptide (BNP) ELISA Kit, 96 tests, quantitative

100-400-BNP 1 kit
EUR 927.6

Human Heat Shock Protein 90 (HSP90) ELISA Kit, 96 tests, Quantitative

100-380-H90 1 Kit
EUR 927.6

Human Heme Oxygenase (HO/HMOX1/HSP32) ELISA Kit, 96 tests, Quantitative

100-540-HO1 1 Kit
EUR 854.4

Human Cathepsin L (CTSL/STSL1/CATL1) ELISA Kit, 96 tests, quantitative

100-680-CLH 1 kit
EUR 1000.8

Human Pancreatic Elastase-1 (ELA1/CELA1) ELISA Kit, 96 tests, quantitative

100-500-ELA 1 kit
EUR 1147.2

Bacillus anthracis (Anthrax) antibody (Lethal Factor)

10-B03A 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor)

Bacillus anthracis (Anthrax) antibody (Lethal Factor)

10-B03B 1 mg
EUR 410
Description: Mouse monoclonal Bacillus anthracis (Anthrax) antibody (Lethal Factor)

Digital dermatitis ELISA kit A

10-0030-1 1 kit
EUR 678

Human Bone Morphogenic Protein 7 (BMP-7) ELISA Kit, 96 tests, Quantitative

100-190-B7H 1 Kit
EUR 1000.8

Human Interleukin Receptor 1 A (IL-1RA) ELISA Kit, 96 tests, quantitative

100-420-IRA 1 kit
EUR 781.2

Human Cathepsin B (CTSB/CPSB/Catherpsin B1) ELISA Kit, 96 tests, quantitative

100-640-CBH 1 kit
EUR 1000.8

EBOV Soluble GP (sGP) ELISA Kit

0100-001 1ea
EUR 525
Description: quantitative measurement of EBOV soluble glycoprotein in mouse and non-human primate sera

SUDV Soluble GP (sGP) ELISA Kit

0102-001 1ea
EUR 525
Description: quantitative measurement of SUDV soluble glycoprotein in mouse and non-human primate sera

Human Cartilage oligomeric matrix protein (COMP) ELISA KIT, 96 tests, quantitative

100-440-COMP 1 kit
EUR 927.6

Human Neutrophil Peptide-1 (NP-1/HNNP-1) ELISA Kit, 96 tests, Quantitative

100-270-NP1 1 kit
EUR 1074

Human Heat Shock Protein 70 (HSP70/HSP72/DnaK) ELISA Kit, 96 tests, Quantitative

100-360-H70 1 Kit
EUR 927.6

Human Matrix Metalloproteinase-1 (MMP-1/Collagenase) ELISA KIT, 96 tests, quantitative

100-460-MP1 1 kit
EUR 927.6

Human Matrix Metalloproteinase-3 (MMP-3/Collagenase) ELISA KIT, 96 tests, quantitative

100-480-MP3 1 kit
EUR 927.6

Homocysteine ELISA kit, 96 tests, Quantitative

0370-HCY 1 kit
EUR 927.6

ELISA POD Substrate TMB Kit(HYPER)

02893-60 1KIT
EUR 84

ELISA POD Substrate TMB Kit(Popular)

05298-80 1KIT
EUR 56

Mouse VEGF ELISA Kit, 96 tests, Quantitative

100-230-VEM 1 Kit
EUR 854.4

Vitamin B12 ELISA kit, 96 tests, Quantitative

0340-B12 1 Kit
EUR 927.6

Human Insulin & Insulin Analogs (Lispro/Humalog, Aspart, Glargine, Glulisine, Detemir) ELISA Kit, 96 tests,

0035-IA 1 kit
EUR 927.6

Human Granzyme B (GZBM/CathepsinG-like/CGL1/CSPB/CTLA-1) ELISA Kit, 96 tests, quantitative

100-720-CGH 1 kit
EUR 1000.8

Mouse Leptin ELISA Kit, 96 tests, Quantitative

100-130-LEM 1 Kit
EUR 854.4

Mouse Myostatin ELISA Kit, 96 tests, Quantitative

100-220-MYM 1 Kit
EUR 1000.8

Human Eosinophil Protein X (EPX or EDN ) Elastase-1 (ELA1/CELA1) ELISA Kit, 96 tests, quantitative

100-510-EPX 1 kit
EUR 1147.2

Human Calprotectin (neutrophil cytoplasmic protein S100A8/A9, MRP 8/14) ELISA Kit, 96 tests, quantitative

100-520-CPN 1 kit
EUR 1074

Mouse TNF-alpha ELISA Kit, 96 tests, Quantitative

100-210-TNF 1 kit
EUR 578.4

Human IgA ELISA (96 Determinations)

0801197 96T
EUR 432

Human IgG ELISA (96 Determinations)

0801182 96T
EUR 432

Human IgM ELISA (96 Determinations)

0801183 96T
EUR 432

Mouse Resistin/FIZZ3 ELISA Kit, 96 tests, Quantitative

100-120-RSM 1 Kit
EUR 854.4

Prostaglandin E2 (PGE2) ELISA Kit, 96 tests, Quantitative

100-560-PG2 1 Kit
EUR 781.2

Mouse interferon gamma ELISA Kit, 96 tests, Quantitative

100-280-IFG 1 kit
EUR 1220.4

D-Dimer turbidimetric ELISA Kit, 96 tests, Quantitative

0330-DDM 1 kit
EUR 708

Mouse Adiponectin (Acrp30) ELISA Kit, 96 tests, Quantitative

100-150-ADM 1 Kit
EUR 854.4

Human GDF-2 Recombinant Protein

100-383 10 µg
EUR 196.35
Description: GDF-2 belongs to the TGF-ß cytokine family whose members play an important role during prenatal development and postnatal growth, remodeling and maintenance of a variety of tissues and organs. GDF-2 is expressed mainly in nonparenchymal cells of the liver, but is also found in other various cells and tissues. GDF-2 can signal through the ALK1 receptor and has been implicated in a number of physiologic events. These include regulation of the hepatic reticuloendothelial system, glucose homeostasis, and iron homeostasis, as well as the inhibition of angiogenesis. Recombinant human GDF-2 is a 24.1 kDa disulfide linked homodimeric protein consisting of two 110 amino acid polypeptide chains.

Human GDF-2 Recombinant Protein

100-383S 2 µg
EUR 92.4
Description: GDF-2 belongs to the TGF-ß cytokine family whose members play an important role during prenatal development and postnatal growth, remodeling and maintenance of a variety of tissues and organs. GDF-2 is expressed mainly in nonparenchymal cells of the liver, but is also found in other various cells and tissues. GDF-2 can signal through the ALK1 receptor and has been implicated in a number of physiologic events. These include regulation of the hepatic reticuloendothelial system, glucose homeostasis, and iron homeostasis, as well as the inhibition of angiogenesis. Recombinant human GDF-2 is a 24.1 kDa disulfide linked homodimeric protein consisting of two 110 amino acid polypeptide chains.

Vitamin D total (25OH) ELISA kit, 96 tests, Quantitative

0345-VID 1 kit
EUR 708

Bovine Insulin ELISA Kit, 96 tests, Quantitative, 96 tests

0030-10-B1 1 kit
EUR 781.2

Mouse Cathepsin D (CTHD) ELISA Kit, 96 tests, quantitative

100-630-CDM 1 kit
EUR 1000.8

Rat Insulin ELISA Kit, High Sensitivity, Quantitative, 96 tests

0030-50-1 1 kit
EUR 708

Vitamin B9/Folic Acid (FA) ELISA kit, 96 tests, Quantitative

0365-0B9 1 kit
EUR 927.6

Mouse Insulin ELISA Kit, High Sensitivity, Quantitative, 96 tests

0030-40-1 1 kit
EUR 854.4

Rat Insulin ELISA Kit, High Sensitivity, Quantitative, 10x 96 tests

0030-50-10 1 kit
EUR 5833.2

Rat TNF-alpha ELISA Kit, High Sensitivity, 96 tests, Quantitative

100-205-TNR 1 kit
EUR 578.4

Mouse Insulin ELISA Kit, High Sensitivity, Quantitative, 10x 96 tests

0030-40-10 1 kit
EUR 5833.2

Bovine interferon gamma (IFN-gamma) ELISA Kit, 96 tests, Quantitative

100-290-BIG-1 1 kit
EUR 634.8

Mouse/Rat Proinsulin ELISA Kit, High Sensitivity, Quantitative, 96 tests

0030-60-1 1 kit
EUR 1074

Serum Creatinine ELISA kit (colorimetric, all species), 96 tests, quantitative

100-300-SCR 1 kit
EUR 343.2

Mouse/Rat C-Peptide ELISA Kit, High Sensitivity, Quantitative, 96 tests

0030-70-1 1 kit
EUR 1074

Serum Creatinine ELISA kit (colorimetric, all species), 2x96 tests, quantitative

100-305-SCR 1 kit
EUR 562.8

Mouse Cathepsin B (CTSB/CPSB/Catherpsin B1) ELISA Kit, 96 tests, quantitative

100-650-CBM 1 kit
EUR 1000.8

Human GDF-11 Recombinant Protein

100-181 20 µg
EUR 196.35
Description: GDF-11 is a myostatin-homologous protein that acts as an inhibitor of nerve tissue growth. GDF-11 has been shown to suppress neurogenesis through a myostatin-like pathway, which involves arrest of progenitor cell-cycle in the G1 phase. Similarities between myostatin and GDF-11, which are 90% identical in their amino acid sequence, suggests that the regulatory mechanisms responsible for maintaining proper tissue size during neural and muscular development might be the same. Recombinant human GDF-11 is a 25.0 kDa disulfide-linked homodimer containing two 109 amino acid polypeptide chains. It is highly homologous to myostatin/GDF-8 sharing 90% amino-acid sequence identity.

Human GDF-11 Recombinant Protein

100-181S 5 µg
EUR 92.4
Description: GDF-11 is a myostatin-homologous protein that acts as an inhibitor of nerve tissue growth. GDF-11 has been shown to suppress neurogenesis through a myostatin-like pathway, which involves arrest of progenitor cell-cycle in the G1 phase. Similarities between myostatin and GDF-11, which are 90% identical in their amino acid sequence, suggests that the regulatory mechanisms responsible for maintaining proper tissue size during neural and muscular development might be the same. Recombinant human GDF-11 is a 25.0 kDa disulfide-linked homodimer containing two 109 amino acid polypeptide chains. It is highly homologous to myostatin/GDF-8 sharing 90% amino-acid sequence identity.

Human GDF-15/MIC-1 Recombinant Protein

100-338 20 µg
EUR 196.35
Description: GDF-15 belongs to the TGF-β cytokine family whose members play an important role during prenatal development and postnatal growth, remodeling and maintenance of a variety of tissues and organs. GDF-15 is expressed predominantly in placenta and to a much lesser extent in various other tissues. The presence of GDF-15 in amniotic fluid and its elevated levels in the sera of pregnant women suggest a role for GDF-15 in gestation and embryonic development. GDF-15 generally exerts tumor suppressive activities and is one of the predominant factors produced and secreted in response to activation of the p53 pathway. Interestingly, the serum level of GDF-15 is positively correlated with neoplastic progression of several tumor types, including certain colorectal, pancreatic, and prostate cancers. Human GDF-15/MIC-1 is a disulfide linked homodimeric protein consisting of two 114 amino-acid polypeptide chains.

Human GDF-15/MIC-1 Recombinant Protein

100-338S 5 µg
EUR 92.4
Description: GDF-15 belongs to the TGF-β cytokine family whose members play an important role during prenatal development and postnatal growth, remodeling and maintenance of a variety of tissues and organs. GDF-15 is expressed predominantly in placenta and to a much lesser extent in various other tissues. The presence of GDF-15 in amniotic fluid and its elevated levels in the sera of pregnant women suggest a role for GDF-15 in gestation and embryonic development. GDF-15 generally exerts tumor suppressive activities and is one of the predominant factors produced and secreted in response to activation of the p53 pathway. Interestingly, the serum level of GDF-15 is positively correlated with neoplastic progression of several tumor types, including certain colorectal, pancreatic, and prostate cancers. Human GDF-15/MIC-1 is a disulfide linked homodimeric protein consisting of two 114 amino-acid polypeptide chains.

Human GDF-7 Recombinant Protein

100-134 10 µg
EUR 196.35
Description: GDF-7 belongs to the TGF-β superfamily of growth and differentiation factors. It is expressed selectively by roof plate cells that are located in the developing embryonic central nervous system, and has been shown to influence the neuronal identity of cells within the central nervous system. GDF-7 has also been implicated in the formation, maintenance, and repair of certain cartilage and ligament tissue. Recombinant human GDF-7 is a 28 kDa disulfide linked homodimer containing two 129 amino acid residues.

Human GDF-7 Recombinant Protein

100-134S 2 µg
EUR 92.4
Description: GDF-7 belongs to the TGF-β superfamily of growth and differentiation factors. It is expressed selectively by roof plate cells that are located in the developing embryonic central nervous system, and has been shown to influence the neuronal identity of cells within the central nervous system. GDF-7 has also been implicated in the formation, maintenance, and repair of certain cartilage and ligament tissue. Recombinant human GDF-7 is a 28 kDa disulfide linked homodimer containing two 129 amino acid residues.

Human GDF-3 Recombinant Protein

100-179 20 µg
EUR 196.35
Description: GDF-3 is a member of the TGF-β superfamily of growth and differentiation factors, and is highly homologous to GDF-9. Unlike most TGF-β family members, GDF-3 and GDF-9 are not disulfide-linked dimers. GDF-3 is expressed in adult bone marrow, spleen, thymus, and adipose tissue. The expression of GDF-3 is upregulated in high-fat-fed wild-type FABP4/aP2 null mice and was associated with obesity, but not with the related hyperglycemia/hyperinsulinemia which characterizes Type 2 diabetes. Recombinant human GDF-3 is a 26.0 kDa non-disulfide-linked homodimer containing two 114 amino acid polypeptide chains.

Human GDF-3 Recombinant Protein

100-179S 5 µg
EUR 92.4
Description: GDF-3 is a member of the TGF-β superfamily of growth and differentiation factors, and is highly homologous to GDF-9. Unlike most TGF-β family members, GDF-3 and GDF-9 are not disulfide-linked dimers. GDF-3 is expressed in adult bone marrow, spleen, thymus, and adipose tissue. The expression of GDF-3 is upregulated in high-fat-fed wild-type FABP4/aP2 null mice and was associated with obesity, but not with the related hyperglycemia/hyperinsulinemia which characterizes Type 2 diabetes. Recombinant human GDF-3 is a 26.0 kDa non-disulfide-linked homodimer containing two 114 amino acid polypeptide chains.

Human GDF-5 Recombinant Protein

100-389 50 µg
EUR 196.35
Description: GDF-5 is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This group of proteins is characterized by a polybasic proteolytic processing site which is cleaved to produce a mature protein containing seven conserved cysteine residues. The members of this family are regulators of cell growth and differentiation in both embryonic and adult tissues. Mutations in this gene are associated with acromesomelic dysplasia, Hunter-Thompson type; brachydactyly, type C; and chondrodysplasia, Grebe type. These associations confirm that the gene product plays a role in skeletal development. GDF-5 produced in E.Coli is a homodimer, non-glycosylated, polypeptide chain containing 2 x 120 amino acids and having a total molecular mass of 26.8 Dalton.

Human GDF-5 Recombinant Protein

100-389S 10 µg
EUR 92.4
Description: GDF-5 is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This group of proteins is characterized by a polybasic proteolytic processing site which is cleaved to produce a mature protein containing seven conserved cysteine residues. The members of this family are regulators of cell growth and differentiation in both embryonic and adult tissues. Mutations in this gene are associated with acromesomelic dysplasia, Hunter-Thompson type; brachydactyly, type C; and chondrodysplasia, Grebe type. These associations confirm that the gene product plays a role in skeletal development. GDF-5 produced in E.Coli is a homodimer, non-glycosylated, polypeptide chain containing 2 x 120 amino acids and having a total molecular mass of 26.8 Dalton.

Human GDF-3 (Animal Free) Recombinant Protein

100-179-AF 20 µg
EUR 229.95
Description: GDF-3 is a member of the TGF-β superfamily of growth and differentiation factors, and is highly homologous to GDF-9.  Unlike most TGF-β family members, GDF-3 and GDF-9 are not disulfide-linked dimers.  GDF-3 is expressed in adult bone marrow, spleen, thymus, and adipose tissue.  The expression of GDF-3 is upregulated in high-fat-fed wild-type FABP4/aP2 null mice and was associated with obesity, but not with the related hyperglycemia/hyperinsulinemia that characterizes Type 2 diabetes.  Recombinant Human GDF-3 is a 26.0 kDa non-disulfide-linked homodimer containing two 114 amino acid polypeptide chains.

Human GDF-3 (Animal Free) Recombinant Protein

100-179S-AF 5 µg
EUR 134.4
Description: GDF-3 is a member of the TGF-β superfamily of growth and differentiation factors, and is highly homologous to GDF-9.  Unlike most TGF-β family members, GDF-3 and GDF-9 are not disulfide-linked dimers.  GDF-3 is expressed in adult bone marrow, spleen, thymus, and adipose tissue.  The expression of GDF-3 is upregulated in high-fat-fed wild-type FABP4/aP2 null mice and was associated with obesity, but not with the related hyperglycemia/hyperinsulinemia that characterizes Type 2 diabetes.  Recombinant Human GDF-3 is a 26.0 kDa non-disulfide-linked homodimer containing two 114 amino acid polypeptide chains.

Syphilis Antibody ELISA test

100 96T/Box Ask for price
Description: ELISA based test for quantitative detection of Syphilis Antibody

Human BMP-13 (GDF6) Recombinant Protein

100-137 50 µg
EUR 196.35
Description: BMP-13 is expressed in hypertrophic chondrocytes during embryonic development of long bones. Continued postnatal expression of BMP-13 in articular cartilage suggests that it plays a regulatory role in the growth and maintenance of articular cartilage. Adenovirus-mediated BMP-13 gene transfer to rabbit bone marrow stem cells have been reported to augment periosteal repair of osteochondral defects. The functional form of BMP-13/CDMP-2 is a disulfide-linked homodimer of two 120 amino acid polypeptide chains. This 27.5 kDa protein is obtained by proteolytic processing of a biologically inactive precursor protein of 97.7 kDa. Recombinant human BMP-13/CDMP-2 is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains.

Human BMP-13 (GDF6) Recombinant Protein

100-137S 10 µg
EUR 92.4
Description: BMP-13 is expressed in hypertrophic chondrocytes during embryonic development of long bones. Continued postnatal expression of BMP-13 in articular cartilage suggests that it plays a regulatory role in the growth and maintenance of articular cartilage. Adenovirus-mediated BMP-13 gene transfer to rabbit bone marrow stem cells have been reported to augment periosteal repair of osteochondral defects. The functional form of BMP-13/CDMP-2 is a disulfide-linked homodimer of two 120 amino acid polypeptide chains. This 27.5 kDa protein is obtained by proteolytic processing of a biologically inactive precursor protein of 97.7 kDa. Recombinant human BMP-13/CDMP-2 is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains.

10X ELISA Wash Buffer (125 mL)

0801060 125 mL
EUR 19

Protein L Ligand Leakage ELISA

10-0027-1 1 kit
EUR 1400.4

Rat IgG ELISA (96 Determinations)

0801009 96T
EUR 324

Panbio Leptospira IgM ELISA (96w)

02PE10 96 wells/kit
EUR 456.5

Human GDF-5 (BMP-14/CDMP-1, Animal Free) Recombinant Protein

100-389-AF 50 µg
EUR 229.95
Description: GDF-5 is expressed in long bones during embryonic development and postnatally in articular cartilage. Mutations in the GDF-5 gene have been implicated in Hunter-Thompson type dwarfism and in Grebe Syndrome, which is characterized by short stature, extra digits, and short and deformed extremities. The mature and functional form of GDF-5 is a homodimer of two 120 amino-acid polypeptide chain (monomers) linked by a single disulfide bond. Each GDF-5 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 27 amino acid signal peptide and a 354 amino acid propeptide. This precursor undergoes intracellular dimerization, and upon secretion it is processed by a furin-type protease.  Recombinant Human GDF-5 (BMP-14/CDMP-1) is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains.

Human GDF-5 (BMP-14/CDMP-1, Animal Free) Recombinant Protein

100-389S-AF 10 µg
EUR 134.4
Description: GDF-5 is expressed in long bones during embryonic development and postnatally in articular cartilage. Mutations in the GDF-5 gene have been implicated in Hunter-Thompson type dwarfism and in Grebe Syndrome, which is characterized by short stature, extra digits, and short and deformed extremities. The mature and functional form of GDF-5 is a homodimer of two 120 amino-acid polypeptide chain (monomers) linked by a single disulfide bond. Each GDF-5 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 27 amino acid signal peptide and a 354 amino acid propeptide. This precursor undergoes intracellular dimerization, and upon secretion it is processed by a furin-type protease.  Recombinant Human GDF-5 (BMP-14/CDMP-1) is a 27.0 kDa homodimeric disulfide-linked protein consisting of two 120 amino acid polypeptide chains.

Goat IgG ELISA (96 Determinations)

0801223 96T
EUR 324

Mouse IgG ELISA (96 Determinations)

0801180 96T
EUR 432

Horse IgG ELISA (96 Determinations)

0801221 96T
EUR 324

Mouse IgM ELISA (96 Determinations)

0801181 96T
EUR 432

Bovine IgG ELISA (96 Determinations)

0801198 96T
EUR 445

Rabbit IgG ELISA (96 Determinations)

0801202 96T
EUR 432

Chicken IgY ELISA (96 Determinations)

0801010 96T
EUR 324

ELISA PLATE READER : MICRO READ 1000

1000 1 unit
EUR 2628

Protein L Ligand Leakage ELISA XL

10-0028-1 1 kit
EUR 1563.6

ELISA POD Substrate TMB Solution(Easy)

05299-54 100ML
EUR 57.4

Guinea Pig IgG ELISA (96 Determinations)

0801029 96T
EUR 445

Human anti-(C. difficile toxin B) mAb

0250-002 100ug
EUR 425
Description: Human antibody produced in N. benthamiana and is reactive to C. difficile toxin B.

Human anti-(C. difficile toxin A) mAb

0250-001 100ug
EUR 425
Description: Human antibody produced in N. benthamiana and is reactive to C. difficile toxin A.

HTLV p19 Antigen ELISA (96 Determinations)

0801116 96T
EUR 774

Signal Enhancer HIKARI for Western Blotting and ELISA (250ml)

02270-81 1SET
EUR 210

ELISA Construction System (5 X 96 Determinations)

0801188 5 X 96T
EUR 345

HIV Type 1 p24 Antigen ELISA (96 Determinations)

0801111 96T
EUR 621

HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations)

0801002 96T
EUR 657.79
Description: Please contact Gentaur in order to receive the datasheet of the product.

ELISA Grade Bovine Type I Collagen, 0.5 mg/ml x 1ml

1002 0.5 mg/ml x 1 ml
EUR 106
Description: ELISA Grade Bovine Type I Collagen

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)

0801200 5 X 96T
EUR 2563

Signal Enhancer HIKARI for Western Blotting and ELISA (50ml)

02267-41 1SET
EUR 70

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)

0801008 5 X 96T
EUR 2505

Signal Enhancer HIKARI for Western Blotting and ELISA Solution A

02272-74 250ML
EUR 119

Signal Enhancer HIKARI for Western Blotting and ELISA Solution B

02297-64 250ML
EUR 119

Simian Immunodeficiency Virus (SIV) p27 Antigen ELISA (96 Determinations)

0801169 96T
EUR 774

Simian Immunodeficiency Virus (SIV) p27 Antigen ELISA (5 X 96 Determinations)

0801201 5 X 96 Determinations
EUR 3213

Foil pouch and silica gel pack for storage of microtitre (ELISA) plates (10 pcs)

100191 10 pcs
EUR 22
Description: Foil pouch and silica gel pack for storage of microtitre (ELISA) plates (10 pcs)

rhIL-2 Recombinant Human Interleukin-2 (20,000 Units)

0801114 20,000 Units
EUR 95

Human IGF-2 Recombinant Protein

100-041 50 µg
EUR 196.35
Description: The IGFs are mitogenic polypeptide growth factors that stimulate the proliferation and survival of various cell types including muscle, bone, and cartilage tissue in vitro. IGFs are predominantly produced by the liver, although a variety of tissues produce the IGFs at distinctive times. The IGFs belong to the Insulin gene family, which also contains insulin and relaxin. The IGFs are similar by structure and function to insulin, but have a much higher growth-promoting activity than insulin. IGF-II expression is influenced by placenta lactogen, while IGF-I expression is regulated by growth hormone. Both IGF-I and IGF-II signal through the tyrosine kinase type I receptor (IGF-IR), but, IGF-II can also signal through the IGF-II/Mannose-6-phosphate receptor. Mature IGFs are generated by proteolytic processing of inactive precursor proteins, which contain N-terminal and C-terminal propeptide regions. Recombinant human IGF-I and IGF-II are globular proteins containing 70 and 67 amino acids, respectively, and 3 intra-molecular disulfide bonds.

Human IGF-2 Recombinant Protein

100-041S 10 µg
EUR 92.4
Description: The IGFs are mitogenic polypeptide growth factors that stimulate the proliferation and survival of various cell types including muscle, bone, and cartilage tissue in vitro. IGFs are predominantly produced by the liver, although a variety of tissues produce the IGFs at distinctive times. The IGFs belong to the Insulin gene family, which also contains insulin and relaxin. The IGFs are similar by structure and function to insulin, but have a much higher growth-promoting activity than insulin. IGF-II expression is influenced by placenta lactogen, while IGF-I expression is regulated by growth hormone. Both IGF-I and IGF-II signal through the tyrosine kinase type I receptor (IGF-IR), but, IGF-II can also signal through the IGF-II/Mannose-6-phosphate receptor. Mature IGFs are generated by proteolytic processing of inactive precursor proteins, which contain N-terminal and C-terminal propeptide regions. Recombinant human IGF-I and IGF-II are globular proteins containing 70 and 67 amino acids, respectively, and 3 intra-molecular disulfide bonds.

Human BMP-2 Recombinant Protein

100-048 10 µg
EUR 196.35
Description: BMPs (Bone Morphogenetic Proteins) belong to the TGF-β superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with an osteoconductive carrier such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 appears to play an important role in cardiac morphogenesis, and is expressed in a variety of other tissues, including lung, liver, spleen, prostate, ovary, and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains (monomers) linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant Human BMP-2 derived from CHO cells is a homodimeric glycoprotein that consists of two 114 amino acid polypeptide chains linked by a single disulfide bond. Due to glycosylation, CHO cell-derived Human BMP-2 migrates at an apparent molecular weight of approximately 28-29 kDa by SDS-PAGE analysis under non-reducing conditions.

Human BMP-2 Recombinant Protein

100-048S 2 µg
EUR 92.4
Description: BMPs (Bone Morphogenetic Proteins) belong to the TGF-β superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with an osteoconductive carrier such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 appears to play an important role in cardiac morphogenesis, and is expressed in a variety of other tissues, including lung, liver, spleen, prostate, ovary, and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains (monomers) linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant Human/Murine/Rat BMP-2 derived from CHO cells is a homodimeric glycoprotein that consists of two 114 amino acid polypeptide chains linked by a single disulfide bond. Due to glycosylation, CHO cell-derived Human/Murine/Rat BMP-2 migrates at an apparent molecular weight of approximately 28-29 kDa by SDS-PAGE analysis under non-reducing conditions.

Human TFF-2 Recombinant Protein

100-289 20 µg
EUR 196.35
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 106 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds.

Human TFF-2 Recombinant Protein

100-289S 5 µg
EUR 92.4
Description: The Trefoil Factor peptides (TFF1, TFF2 and TFF3) are expressed in the gastrointestinal tract, and appear to play an important role in intestinal mucosal defense and repair. TFF2 has been shown to inhibit gastrointestinal motility and gastric acid secretion. Recent data suggests a potential role for TFF2 in acute and chronic asthma (Nikolaidis, N.M. et al. Am. Journal Respir. Cell Mol. Biol. (2003) 4: 458-464). Recombinant human TFF2 is a 12.0 kDa polypeptide of 106 amino acid residues, which includes a 40-amino acid trefoil motif containing three conserved intramolecular disulfide bonds.

Human MMP-2 Recombinant Protein

100-372 10 µg
EUR 196.35
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids).

Human MMP-2 Recombinant Protein

100-372S 2 µg
EUR 92.4
Description: Matrix metalloproteinases (MMPs) are a family of endoproteases that require zinc and calcium for expressing catalytic activity. These enzymes play a central role in the maintenance and remodeling of the extracellular matrix. Elevated expression of their activity, caused either by up-regulation of their expression or down-regulation of their cognate inhibitors, has been implicated in various degenerative disorders, including arthritis, cardiovascular disease, skeletal growth-plate disorders, and cancer metastasis. MMP-2 is a secreted collagenase with specificity toward Type IV, V, VII, and X collagens. Recombinant human MMP-2 is a 62.0 kDa protein containing the entire catalytic N-terminal domain and the C-terminal domain (552 amino acids).

Human PAI-2 Recombinant Protein

100-425 10 µg
EUR 196.35
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.

Human PAI-2 Recombinant Protein

100-425S 2 µg
EUR 92.4
Description: PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.

human Dkk-2 Recombinant Protein

100-436 10 µg
EUR 196.35
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-11 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains. Playing an important regulatory role in vertebrate development through localized inhibition of Wnt-regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-2 has been shown to both inhibit and enhance canonical Wnt signaling; enhancing Wnt signaling through direct high-affinity binding of DKK-2 to LRP6 during LRP6 overexpression, while inhibiting Wnt signaling and promoting LRP6 internalization through the formation of a ternary complex between DKK-2, LRP6, and Kremen-2. Recombinant Human DKK-2 expressed in CHO cells is a glycoprotein that has a calculated molecular weight of 25.8 kDa and contains 234 amino acid residues. Due to glycosylation, human DKK-2 migrates at an apparent molecular weight of approximately 31-36 kDa by SDS-PAGE analysis under non-reducing conditions.

human Dkk-2 Recombinant Protein

100-436S 2 µg
EUR 92.4
Description: The dickkopf (DKK)-related protein family is comprised of four central members, DKK-1 - 4, along with the distantly-related DKK family member DKK-11 (Soggy), which is thought to be a descendent of an ancestral DKK-3 precursor due to its unique sequence homology to DKK-3 and no other DKK family member. DKK family members, with the exception of the divergent Soggy, share two conserved cysteine-rich domains and show very little sequence similarity outside of these domains. Playing an important regulatory role in vertebrate development through localized inhibition of Wnt-regulated processes, including anterior-posterior axial patterning, limb development, somitogenesis, and eye formation, DKKs have also been implicated post-developmentally in bone formation, bone disease, cancer, and neurodegenerative diseases. DKK proteins typically play an important regulatory role in the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LDL receptor-related proteins 5 and 6 (LRP5 and LRP6), which are essential components of the Wnt/β-catenin signaling system. LRP5 and LRP6 are single-pass transmembrane proteins that appear to act as co-receptors for Wnt ligands involved in the Wnt/β-catenin signaling cascade. DKK-2 has been shown to both inhibit and enhance canonical Wnt signaling; enhancing Wnt signaling through direct high-affinity binding of DKK-2 to LRP6 during LRP6 overexpression, while inhibiting Wnt signaling and promoting LRP6 internalization through the formation of a ternary complex between DKK-2, LRP6, and Kremen-2. Recombinant Human DKK-2 expressed in CHO cells is a glycoprotein that has a calculated molecular weight of 25.8 kDa and contains 234 amino acid residues. Due to glycosylation, human DKK-2 migrates at an apparent molecular weight of approximately 31-36 kDa by SDS-PAGE analysis under non-reducing conditions.

Human TAFA-2 Recombinant Protein

100-359 20 µg
EUR 196.35
Description: TAFA proteins are a newly discovered family of proteins, which are distantly related to MIP-1α, a member of the CC-chemokine family. TAFA mRNAs are highly expressed in specific brain regions, and have also been found to be expressed by lung basophils. The biological function of TAFA-2 is still unknown. Recombinant human TAFA-2 is an 11.2 kDa protein consisting of 101 amino acid residues.

Human TAFA-2 Recombinant Protein

100-359S 5 µg
EUR 92.4
Description: TAFA proteins are a newly discovered family of proteins, which are distantly related to MIP-1α, a member of the CC-chemokine family. TAFA mRNAs are highly expressed in specific brain regions, and have also been found to be expressed by lung basophils. The biological function of TAFA-2 is still unknown. Recombinant human TAFA-2 is an 11.2 kDa protein consisting of 101 amino acid residues.

Human TIMP-2 Recombinant Protein

100-431 10 µg
EUR 196.35
Description: TIMP-2 is an extracellular inhibitor of MMPs including MMP1, 2, 3, 7, 8, 9, 10, 12, 13, 14, 15, 16 and 19. It belongs to the I35 (TIMP) family of irreversible protease inhibitors that function as key modulators of extracellular matrix degradation during tissue development and remodeling. TIMP-2 can also act through an MMP-independent mechanism inhibiting endothelial cell proliferation in vitro and demonstrates anti-angiogenic activities in vivo. Recombinant human TIMP-2 is a 21.8 kDa protein containing 194 amino acid residues.

Human TIMP-2 Recombinant Protein

100-431S 2 µg
EUR 92.4
Description: TIMP-2 is an extracellular inhibitor of MMPs including MMP1, 2, 3, 7, 8, 9, 10, 12, 13, 14, 15, 16 and 19. It belongs to the I35 (TIMP) family of irreversible protease inhibitors that function as key modulators of extracellular matrix degradation during tissue development and remodeling. TIMP-2 can also act through an MMP-independent mechanism inhibiting endothelial cell proliferation in vitro and demonstrates anti-angiogenic activities in vivo. Recombinant human TIMP-2 is a 21.8 kDa protein containing 194 amino acid residues.

Human Relaxin-2 Recombinant Protein

100-113 25 µg
EUR 196.35
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain.

Human Relaxin-2 Recombinant Protein

100-113S 5 µg
EUR 92.4
Description: Relaxin-2 is a peptide hormone structurally related to insulin, which is expressed in the placenta, decidua, prostate, and in the ovary during pregnancy. Of the three known relaxin genes, Relaxin-2 is the only relaxin known to circulate in the blood. Relaxin-2 binds specifically to the LGR7 and LGR8 receptors, previously identified as an “orphan” G protein coupled receptors. Signaling by Relaxin-2 through its target receptors enhances the growth of pubic ligaments and ripening of the cervix during birth. Recombinant Relaxin-2 is a nonglycosylated 6.0 kDa disulfide linked heterodimeric protein consisting of a 24 amino acid A-chain and a 29 amino acid B-chain.

Human Prokineticin-2 Recombinant Protein

100-272 20 µg
EUR 196.35
Description: Prokineticin-2 (PK2) is a cysteine-rich secreted protein that is expressed in the testis and in lower levels of the small intestine. PK2 regulates various biological functions including gastrointestinal motility, angiogenesis and circadiam rhythms. It is closely related to EG-VEGF (Prokineticin-1) and binds to two orphan B-protein-coupled receptors termed PK-R1 and PK-R2. Recombinant human Prokineticin-2 is an 8.8 kDa protein consisting of 81 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

Human Prokineticin-2 Recombinant Protein

100-272S 5 µg
EUR 92.4
Description: Prokineticin-2 (PK2) is a cysteine-rich secreted protein that is expressed in the testis and in lower levels of the small intestine. PK2 regulates various biological functions including gastrointestinal motility, angiogenesis and circadiam rhythms. It is closely related to EG-VEGF (Prokineticin-1) and binds to two orphan B-protein-coupled receptors termed PK-R1 and PK-R2. Recombinant human Prokineticin-2 is an 8.8 kDa protein consisting of 81 amino acid residues and ten cysteine residues that potentially form five pairs of intra-molecular disulfide bonds.

Human MIA-2 (Melanoma inhibitory activity 2) Recombinant Protein

100-348 20 µg
EUR 196.35
Description: MIA2 is a secreted cytokine and a member of the MIA/OTOR family. Members of this family which also includes MIA, OTOR, and TANGO share a Src homology-3 (SH3)-like domain. MIA2 is predominantly expressed in hepatocytes. Elevated levels of MIA2 may represent a clinically useful marker for diagnosis of hepatic disease activity and severity. Recombinant human MIA-2 is a 101 amino acid, 11.5 kDa protein comprising the MIA homologous N-terminal region of the full length MIA-2 protein.

Human MIA-2 (Melanoma inhibitory activity 2) Recombinant Protein

100-348S 5 µg
EUR 92.4
Description: MIA2 is a secreted cytokine and a member of the MIA/OTOR family. Members of this family which also includes MIA, OTOR, and TANGO share a Src homology-3 (SH3)-like domain. MIA2 is predominantly expressed in hepatocytes. Elevated levels of MIA2 may represent a clinically useful marker for diagnosis of hepatic disease activity and severity. Recombinant human MIA-2 is a 101 amino acid, 11.5 kDa protein comprising the MIA homologous N-terminal region of the full length MIA-2 protein.

Human BD-2 (SAP1) Recombinant Protein

100-004 20 µg
EUR 196.35
Description: Human ß-defensin-2 (BD-2) is an antimicrobial peptide which belongs to the distinct family of ß-defensins. Recent studies have shown that the ß-defensins are present in the human airways and may be relevant to the pathogenesis of cystic fibrosis lung disease. Human BD-2 is a 4.3 kDa protein containing 43 amino acid residues.

Human BD-2 (SAP1) Recombinant Protein

100-004S 5 µg
EUR 92.4
Description: Human ß-defensin-2 (BD-2) is an antimicrobial peptide which belongs to the distinct family of ß-defensins. Recent studies have shown that the ß-defensins are present in the human airways and may be relevant to the pathogenesis of cystic fibrosis lung disease. Human BD-2 is a 4.3 kDa protein containing 43 amino acid residues.

Human ICAM-2 Fc Recombinant Protein

100-342 50 µg
EUR 196.35
Description: Intracellular adhesion molecule‐2 (ICAM‐2), also known as CD102, is a member of the Ig superfamily of calcium‐ independent transmembrane glycoproteins. ICAM‐2 is a ligand for the β2‐integrins, lymphocyte function‐ associated antigen‐1 (LFA‐1) and Mac‐1. Constitutively expressed on all vascular endothelial cells and at endothelial cell junctions, it is also expressed at low levels on most leukocytes. As a cell surface adhesion molecule, it is involved in leukocyte recruitment and mediates leukocyte binding. Through interaction with LFA‐1, ICAM‐2 activates the PI3K/AKT pathway which leads to inhibition of TNF‐α and Fas‐mediated apoptosis. ICAM‐2 is highly expressed in lymphomas and it is postulated to be involved in lymphocyte recirculation and trafficking. T cell crawling and diapedesis across the blood‐brain barrier has been shown to be regulated by ICAM‐2 via ligation of LFA‐1 as well as neutrophil crawling and IL‐1ß‐stimulated extravasation through ligation of Mac‐1. ICAM‐2 has been shown to suppress neuroblastoma cell motility by binding with the cytoskeletal linker protein α‐actinin which, in turn, regulates metastasis. Additionally, it has been found to enhance the immune response in colon carcinoma cells and induce an antitumor immune response in pancreatic carcinogenesis. The CHO‐derived Recombinant Human ICAM‐2 Fc is a glycosylated, disulfide‐linked homodimer of 435 amino‐acid‐residues whose monomer consists of the 202‐amino‐acid extracellular portion of ICAM‐2 fused to the 231 amino‐acid length Fc portion of human IgG by two glycine residues. The calculated molecular weight of monomeric CHO cell‐derived Recombinant Human ICAM‐2 Fc is 48.5 kDa; however, due to glycosylation, it migrates at an apparent molecular weight of approximately 70‐80 kDa by SDS‐PAGE analysis under reducing conditions.

Human ICAM-2 Fc Recombinant Protein

100-342S 10 µg
EUR 92.4
Description: Intracellular adhesion molecule‐2 (ICAM‐2), also known as CD102, is a member of the Ig superfamily of calcium‐ independent transmembrane glycoproteins. ICAM‐2 is a ligand for the β2‐integrins, lymphocyte function‐ associated antigen‐1 (LFA‐1) and Mac‐1. Constitutively expressed on all vascular endothelial cells and at endothelial cell junctions, it is also expressed at low levels on most leukocytes. As a cell surface adhesion molecule, it is involved in leukocyte recruitment and mediates leukocyte binding. Through interaction with LFA‐1, ICAM‐2 activates the PI3K/AKT pathway which leads to inhibition of TNF‐α and Fas‐mediated apoptosis. ICAM‐2 is highly expressed in lymphomas and it is postulated to be involved in lymphocyte recirculation and trafficking. T cell crawling and diapedesis across the blood‐brain barrier has been shown to be regulated by ICAM‐2 via ligation of LFA‐1 as well as neutrophil crawling and IL‐1ß‐stimulated extravasation through ligation of Mac‐1. ICAM‐2 has been shown to suppress neuroblastoma cell motility by binding with the cytoskeletal linker protein α‐actinin which, in turn, regulates metastasis. Additionally, it has been found to enhance the immune response in colon carcinoma cells and induce an antitumor immune response in pancreatic carcinogenesis. The CHO‐derived Recombinant Human ICAM‐2 Fc is a glycosylated, disulfide‐linked homodimer of 435 amino‐acid‐residues whose monomer consists of the 202‐amino‐acid extracellular portion of ICAM‐2 fused to the 231 amino‐acid length Fc portion of human IgG by two glycine residues. The calculated molecular weight of monomeric CHO cell‐derived Recombinant Human ICAM‐2 Fc is 48.5 kDa; however, due to glycosylation, it migrates at an apparent molecular weight of approximately 70‐80 kDa by SDS‐PAGE analysis under reducing conditions.

Human MD-2/LY96 Recombinant Protein

100-443 50 µg
EUR 196.35
Description: Myeloid differentiation protein-2 (MD-2), also referred to as LY69, is an accessory glycoprotein secreted in hematopoietic, nervous, and reproductive tissues at various stages of development where it regulates innate immune responses to microbial pathogens through interaction with the extracellular do mains of TLR-2 and TLR-4. The association of MD-2 with the extracellular domain of TLR-4, which is constitutively expressed in cells of the immune system, localizes TLR-4 to the cell surface and forms the TLR-4/MD-2 receptor complex necessary for signal transduction in response to inflammatory signals. The activation of TLR-4/MD-2 begins with the detection of LPS by circulating LPS-Binding Protein (LBP), which in turn facilitates an association between LPS and CD14 for the formation of a CD14/LPS complex that transports and presents LPS to the TLR-4/MD-2 signaling complex, and culminates in the activation of downstream signaling events. MD-2’s possession of two dedicated functional domains allows for its simultaneous interaction with both TLR-4 and LPS,the major cell wall component of gram-negative bacteria that acts as the key ligand for TLR-4. Response to LPS is an intricate process that involves several co-stimulatory molecules, including myeloid differentiation factor 88 (MyD88), NF-κB, LBP, and CD14, in addition to TLR-4 and MD-2, and results in the secretion of proinflammatory cytokines and chemokines from the NF-κB, Wnt/β-catenin, and mitogen-activated protein kinase (MAPK) pathways. MD-2 interacts with TLR-2 in a similar, albeit far weaker, manner to initiate immune response to cell wall components of both gram-negative and gram-positive bacteria. Once secreted, MD-2 can polymerize into a heterogenous collection of large, disulfide-linked oligomers that are each able to bind several TLR-4 molecules, resulting in large clusters localized to the cell surface prior to activation. The HEK293 cell-derived Recombinant Human MD-2/LY96 is a disulfide-linked homodimer whose monomer contains 148 amino acid residues, including a C-terminal His tag, and has a calculated molecular weight of 17.2 kDa.

Human MD-2/LY96 Recombinant Protein

100-443S 10 µg
EUR 92.4
Description: Myeloid differentiation protein-2 (MD-2), also referred to as LY69, is an accessory glycoprotein secreted in hematopoietic, nervous, and reproductive tissues at various stages of development where it regulates innate immune responses to microbial pathogens through interaction with the extracellular do mains of TLR-2 and TLR-4. The association of MD-2 with the extracellular domain of TLR-4, which is constitutively expressed in cells of the immune system, localizes TLR-4 to the cell surface and forms the TLR-4/MD-2 receptor complex necessary for signal transduction in response to inflammatory signals. The activation of TLR-4/MD-2 begins with the detection of LPS by circulating LPS-Binding Protein (LBP), which in turn facilitates an association between LPS and CD14 for the formation of a CD14/LPS complex that transports and presents LPS to the TLR-4/MD-2 signaling complex, and culminates in the activation of downstream signaling events. MD-2’s possession of two dedicated functional domains allows for its simultaneous interaction with both TLR-4 and LPS,the major cell wall component of gram-negative bacteria that acts as the key ligand for TLR-4. Response to LPS is an intricate process that involves several co-stimulatory molecules, including myeloid differentiation factor 88 (MyD88), NF-κB, LBP, and CD14, in addition to TLR-4 and MD-2, and results in the secretion of proinflammatory cytokines and chemokines from the NF-κB, Wnt/β-catenin, and mitogen-activated protein kinase (MAPK) pathways. MD-2 interacts with TLR-2 in a similar, albeit far weaker, manner to initiate immune response to cell wall components of both gram-negative and gram-positive bacteria. Once secreted, MD-2 can polymerize into a heterogenous collection of large, disulfide-linked oligomers that are each able to bind several TLR-4 molecules, resulting in large clusters localized to the cell surface prior to activation. The HEK293 cell-derived Recombinant Human MD-2/LY96 is a disulfide-linked homodimer whose monomer contains 148 amino acid residues, including a C-terminal His tag, and has a calculated molecular weight of 17.2 kDa.

LIMITED QTY-rhIL-2 Recombinant Human Interleukin-2 (100 µg)

0802001 100 µg
EUR 434.4
Description: Please contact Gentaur in order to receive the datasheet of the product.

Human MCP-2 (CCL8) Recombinant Protein

100-066 10 µg
EUR 196.35
Description: The MCP proteins belong to the CC chemokine family, and signal through CCR2 and, with the exception of MCP-1, other CCR receptors. The MCP proteins chemoattract and activate monocytes, activated T cells, basophils, NK cells, and immature dendritic cells. The MCP family cross reacts across species. Recombinant human MCP-2 is an 8.9 kDa protein containing 76 amino acid residues including the four highly conserved cysteine residues present in the CC chemokines.

Human MCP-2 (CCL8) Recombinant Protein

100-066S 2 µg
EUR 92.4
Description: The MCP proteins belong to the CC chemokine family, and signal through CCR2 and, with the exception of MCP-1, other CCR receptors. The MCP proteins chemoattract and activate monocytes, activated T cells, basophils, NK cells, and immature dendritic cells. The MCP family cross reacts across species. Recombinant human MCP-2 is an 8.9 kDa protein containing 76 amino acid residues including the four highly conserved cysteine residues present in the CC chemokines.

Human GCP-2 (CXCL6) Recombinant Protein

100-028 20 µg
EUR 196.35
Description: GCP-2 is a connective tissue derived CXC chemokine that can signal through the CXCR1 and CXCR2 receptors.  GCP-2 selectively attracts neutrophils and has also been shown to exert anti-angiogenic activity.  Human GCP-2 is cross-react on murine cells.  Recombinant human GCP-2 is a 7.9 kDa protein containing 72 amino acid residues.

Human GCP-2 (CXCL6) Recombinant Protein

100-028S 5 µg
EUR 92.4
Description: GCP-2 is a connective tissue derived CXC chemokine that can signal through the CXCR1 and CXCR2 receptors.  GCP-2 selectively attracts neutrophils and has also been shown to exert anti-angiogenic activity.  Human GCP-2 is cross-react on murine cells.  Recombinant human GCP-2 is a 7.9 kDa protein containing 72 amino acid residues.

Human GDF2(Growth Differentiation Factor 2) ELISA Kit

Scroll to Top